PMC:7243778 / 36865-37097
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
960 | 73-78 | Gene | denotes | gp120 | Gene:3700 |
961 | 97-98 | Gene | denotes | S | Gene:43740568 |
964 | 110-120 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
972 | 90-93 | Disease | denotes | HIV | MESH:D015658 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T178 | 59-72 | Body_part | denotes | glycoproteins | http://purl.org/sig/ont/fma/fma62925 |
T179 | 90-93 | Body_part | denotes | HIV | http://purl.org/sig/ont/fma/fma278683 |
T180 | 99-106 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T190 | 110-118 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T424 | 50-51 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T425 | 52-57 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T426 | 210-211 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T200 | 22-31 | Chemical | denotes | immunogen | http://purl.obolibrary.org/obo/CHEBI_60816 |
T201 | 59-72 | Chemical | denotes | glycoproteins | http://purl.obolibrary.org/obo/CHEBI_17089 |
T202 | 99-106 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T203 | 217-224 | Chemical | denotes | antigen | http://purl.obolibrary.org/obo/CHEBI_59132 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T32 | 167-182 | http://purl.obolibrary.org/obo/GO_0006955 | denotes | immune response |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T288 | 0-232 | Sentence | denotes | Firstly, although the immunogen for protection of a virus, glycoproteins gp120 or gp41 of HIV or S protein of SARS-CoV-2 for example, can be quickly detected, but the immune response needs to be optimized with a good antigen design. |